Trials / Completed
CompletedNCT03292575
Study of the Follow-up of Stroke Treated With Anticoagulants
Prevention of Cardio-embolic Stroke Using Anti-vitamin K and Direct Oral Anticoagulants. A Model of Action in Burgundy.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 441 (actual)
- Sponsor
- Centre Hospitalier Universitaire Dijon · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Stroke is a major public health problem as it is very frequent (140,000 cases/year in France), and very serious (leading cause of death, 2nd leading cause of dementia, 3rd leading cause of handicap). Ischemic cardio-embolic stroke accounts for around 25% of ischemic strokes, and ischemic cardio-embolic stroke in a context of cardiac arrhythmia due to atrial fibrillation (CAAF) is the leading non-atheromatous cause. The aim of this study is to optimise the secondary prevention of CAAF-related stroke identified at the University Hospital of Dijon Burgundy in the framework of the recommendations of the '2010-2014 stroke plan' and the Compulsory Consultation at the 6th month (Directive DGOS//2015/262 of the 3rd August 2015)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anticoagulants |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2017-09-25
- Last updated
- 2019-06-04
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03292575. Inclusion in this directory is not an endorsement.